Pelthos Therapeutics, Inc. (PTHS)
26.66
-0.44
(-1.62%)
USD |
NYAM |
May 22, 16:00
26.75
+0.09
(+0.34%)
After-Hours: 20:00
Pelthos Therapeutics Shareholders Equity (Quarterly) : 35.10M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 319.94M |
| Cibus, Inc. | 35.48M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Agenus, Inc. | -221.22M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.38M |
| Total Liabilities (Quarterly) | 110.28M |
| Debt to Equity Ratio | 1.508 |
| Current Ratio | 2.763 |
| Net Debt Paydown Yield | -73.09% |